biomarker validation study
Clinical research designed to confirm the predictive or prognostic value of molecular markers in cancer treatment.
Full Definition
A biomarker validation study is a systematic clinical investigation that establishes the clinical utility, analytical validity, and clinical validity of molecular markers for cancer diagnosis, prognosis, or treatment selection. These studies require large patient cohorts, standardized assay protocols, and rigorous statistical analysis to demonstrate biomarker performance across diverse populations. Validation studies must address assay reproducibility, cutoff determination, and clinical outcome correlation. Successful biomarker validation studies form the foundation for regulatory approval and clinical guideline development.
Usage
Usage note: Always specify 'validation' to distinguish from discovery studies; capitalize 'Study' in formal protocol titles.
In Context
- "The multicenter biomarker validation study confirmed PD-L1 as a predictive marker for immunotherapy response." — Clinical research protocol
- "Enrollment for the biomarker validation study reached target accrual ahead of schedule." — Clinical trial update